|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 61.5 GBX | 0.00% |
|
0.00% | +18.27% |
| Mar. 19 | Tissue Regenix annual loss narrows sharply as revenue jumps | AN |
| Mar. 19 | Earnings Flash (TRX.L) TISSUE REGENIX GROUP Reports FY23 Revenue $29.5M | MT |
Tissue Regenix Group plc reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 29.49 million compared to USD 24.48 million a year ago. Net loss was USD 1.71 million compared to USD 2.7 million a year ago.
Basic loss per share from continuing operations was USD 0.0243 compared to USD 0.0383 a year ago. Diluted loss per share from continuing operations was USD 0.0243 compared to USD 0.0383 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +18.27% | 53.94M | |
| +4.36% | 32.47B | |
| +14.14% | 7.45B | |
| +22.93% | 3.89B | |
| -16.29% | 3.15B | |
| -25.96% | 1.28B | |
| -36.14% | 1.09B | |
| -35.42% | 902M | |
| -0.13% | 893M | |
| -24.12% | 857M |
TISSUE REGENIX GROUP PLC 
